StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report released on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Performance NASDAQ NVIV opened at $1.16 on Friday. The firm has a 50 day simple moving average of $1.23 and a […]
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a report issued on Thursday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance Shares of NVIV opened at $1.16 on Thursday. InVivo Therapeutics has a one year low of $0.81 and a one year high […]
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research note issued to investors on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Trading Up 4.4 % Shares of InVivo Therapeutics stock opened at $1.19 on Wednesday. InVivo Therapeutics has a 1 year low […]
StockNews.com assumed coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a report published on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Performance Shares of NASDAQ:NVIV opened at $1.17 on Tuesday. The company has a market cap of $3.64 million, a P/E ratio of -0.14 […]
StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Performance NVIV stock opened at $1.20 on Tuesday. The company’s 50 day moving average price is $1.29 and its 200 day moving […]